Загрузка...
Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway
BACKGROUND: Many types of cancers are devoid of the small leucine-rich proteoglycans: osteoglycin (OGN), but its role in tumorigenesis is poorly studied especially in colorectal cancers (CRC). Here we aim to evaluate the relationship between OGN expression patterns and the clinical course of CRC, an...
Сохранить в:
| Опубликовано в: : | J Exp Clin Cancer Res |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5833032/ https://ncbi.nlm.nih.gov/pubmed/29499765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-018-0718-2 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|